Practice pattern of gastroenterologists for the management of GERD under the minimal influence of the insurance reimbursement guideline: A multicenter prospective observational study

Journal of Korean Medical Science

Volumn 26, Issue 12, 2011, Pages 1613-1618

  Lee, Kwang Jae ^a   Kim, Jin Il ^b   Park, Ju Sang ^c   Moon, Byung Sik ^d   Kim, Sang Gyun ^e   Chun, Jae Hee ^f   Jung, Hoon Yong ^g   Choi, Chang Hwan ^h   Chun, Seong Woo ⁱ   Song, Geun Am ^j   Choi, Myung Gyu ^b   Chun, Hoon Jai ^k  

^a Ajou University School of Medicine   (South Korea)

^b The Catholic University of Korea College of Medicine   (South Korea)

^c Department of Internal Medicine   (South Korea)

^d Sejong Hospital   (South Korea)

^e Seoul National University College of Medicine   (South Korea)

^f Yonsei University College of Medicine   (South Korea)

^g University of Ulsan College of Medicine   (South Korea)

^h Chung Ang University College of Medicine   (South Korea)

ⁱ Kyungpook National University School of Medicine   (South Korea)

^j Pusan National University School of Medicine   (South Korea)

^k Korea University College of Medicine   (South Korea)

more..

Author keywords

Gastroesophageal reflux disease; Korea; Proton pump inhibitors

Indexed keywords

2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; ENZYME INHIBITOR; PROTON PUMP INHIBITOR; RABEPRAZOLE;

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; FEMALE; GASTROENTEROLOGY; GASTROESOPHAGEAL REFLUX; HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PRACTICE GUIDELINE; REIMBURSEMENT; SOUTH KOREA; TREATMENT OUTCOME;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; AGED, 80 AND OVER; ENZYME INHIBITORS; FEMALE; GASTROENTEROLOGY; GASTROESOPHAGEAL REFLUX; GUIDELINE ADHERENCE; HUMANS; INSURANCE, HEALTH, REIMBURSEMENT; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PROTON PUMP INHIBITORS; REPUBLIC OF KOREA; TREATMENT OUTCOME;

EID: 84863039489     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2011.26.12.1613     Document Type: Article

References (20)

1. Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-esophageal reflux disease: a systematic review. Gut 2005; 54: 710-7.
2. Wong BC, Kinoshita Y. Systematic review on epidemiology of gastroesophageal reflux disease in Asia. Clin Gastroenterol Hepatol 2006; 4: 398-407.
3. Yang SY, Lee OY, Bak YT, Jun DW, Lee SP, Lee SH, Park GT, Yoon BC, Choi HS, Hahm JS, Lee MH, Lee DH. Prevalence of gastroesophageal reflux disease symptoms and uninvestigated dyspepsia in Korea: a populationbased study. Dig Dis Sci 2008; 53: 188-93.
4. Cho YS, Choi MG, Jeong JJ, Chung WC, Lee IS, Kim SW, Han SW, Choi KY, Chung IS. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Asan-si, Korea. Am J Gastroenterol 2005; 100: 747-53.
5. Lee SY, Lee KJ, Kim SJ, Cho SW. Prevalence and risk factors for overlaps between gastroesophageal reflux disease, dyspepsia, and irritable bowel syndrome: a population-based study. Digestion 2009; 79: 196-201.
6. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101: 1900-20.
7. Dent J, Brun J, Fendrick AM, Fennerty MB, Janssens J, Kahrilas P, Lauritsen K, Reynolds JC, Shaw M, Talley N. An evidence-based appraisal of reflux disease management: the Genval Workshop Report. Gut 1998; 44: S1-16.
8. Fock KM, Talley NJ, Fass R, Goh KL, Katelaris P, Hunt R, Hongo M, Ang TL, Holtmann G, Nandurkar S, Lin SR, Wong BC, Chan FK, Rani AA, Bak YT, Sollano J, Ho KY, Manatsathit S. Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. J Gastroenterol Hepatol 2008; 23: 8-22.
9. Lim SL, Goh WT, Lee JM, Ng TP, Ho KY. Community Medicine GI Study Group. Changing prevalence of gastroesophageal reflux with changing time: longitudinal study in an Asian population. J Gastroenterol Hepatol 2005; 20: 995-1001.
10. Ho KY, Chan YH, Kang JY. Increasing trend of reflux esophagitis and decreasing trend of Helicobacter pylori infection in patients from a multiethnic Asian country. Am J Gastroenterol 2005; 100: 1923-8.
11. Sollano JD, Wong SN, Andal-Gamutan T, Chan MM, Carpio RE, Tady CS, Ismael AE, Judan-Ruiz EA, Ang VN, Go JT, Lim VY, Perez JY, Alvarez SZ. Erosive esophagitis in the Philippines: a comparison between two time periods. J Gastroenterol Hepatol 2007; 22: 1650-5.
12. Ha NR, Lee HL, Lee OY, Yoon BC, Choi HS, Hahm JS, Ahn YH, Koh DH. Differences in clinical characteristics between patients with non-erosive reflux disease and erosive esophagitis in Korea. J Korean Med Sci 2010; 25: 1318-22.
13. Lee KJ, Kwon HC, Cheong JY, Cho SW. Demographic, clinical, and psychological characteristics of the heartburn groups classified using the Rome III criteria and factors associated with the responsiveness to proton pump inhibitors in the gastroesophageal reflux disease group. Digestion 2009; 79: 131-6.
14. Galmiche JP, Clouse RE, Bálint A, Cook IJ, Kahrilas PJ, Paterson WG, Smout AJ. Functional esophageal disorders. Gastroenterology 2006; 130: 1459-65.
15. Caro JJ, Salas M, Ward A. Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials. Clin Ther 2001; 23: 998-1017.
16. Richter JE, Campbell DR, Kahrilas PJ, Huang B, Fludas C. Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease. Arch Intern Med 2000; 160: 1803-9.
17. Fujiwara Y, Higuchi K, Nebiki H, Chono S, Uno H, Kitada K, Satoh H, Nakagawa K, Kobayashi K, Tominaga K, Watanabe T, Oshitani N, Arakawa T. Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2005; 21: 10-8.
18. Kim YS, Kim TH, Choi CS, Shon YW, Kim SW, Seo GS, Nah YH, Choi MG, Choi SC. Effect of itopride, a new prokinetic, in patients with mild GERD: a pilot study. World J Gastroenterol 2005; 11: 4210-4.
19. Madan K, Ahuja V, Kashyap PC, Sharma MP. Comparison of efficacy of pantoprazole alone versus pantoprazole plus mosapride in therapy of gastroesophageal reflux disease: a randomized trial. Dis Esophagus 2004; 17: 274-8.
20. Kaji M, Fujiwara Y, Shiba M, Kohata Y, Yamagami H, Tanigawa T, Watanabe K, Watanabe T, Tominaga K, Arakawa T. Prevalence of overlaps between GERD, FD and IBS and impact on health-related quality of life. J Gastroenterol Hepatol 2010; 25: 1151-6.